ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

Mefloquine Tablets
Malaria
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

Mefloquine Tablets Rx

Generic Name and Formulations:
Mefloquine (as HCl) 250mg; scored tabs.

Company:
Various generic manufacturers

Therapeutic Use:

Indications for Mefloquine Tablets:

Prophylaxis of P. falciparum (including chloroquine-resistant strains) and P. vivax malaria. Treatment of mild to moderate acute malaria due to susceptible strains of P. falciparum or P. vivax.

Adult:

Take with food and 8oz water. Prophylaxis: 250mg once weekly starting 1 week before departure, continuing during travel to endemic areas and for 4 weeks after return. Treatment: 1250mg as a single dose.

Children:

Give with food and water. May crush tab and mix in water. Prophylaxis: 3–5mg/kg once weekly starting 1 week before departure, continuing during travel to endemic areas and for 4 weeks after return. Treatment: ≤6months of age: contact manufacturer. ≥6months: 20–25mg/kg as single dose or as 2 doses 6–8 hours apart.

Contraindications:

Quinine, quinidine, or related allergy. Not for prophylactic use in patients with psychiatric disorders or history of depression or seizures.

Warnings/Precautions:

Do not use for life-threatening P. falciparum infection. After initial treatment for acute P. vivax infection, follow with an 8-aminoquinoline (eg, primaquine) to eliminate exoerythrocytic phase. Discontinue prophylactic therapy if unexplained CNS disturbances occur. Cardiac disease. Psychiatric disturbances. Seizure disorders. Hepatic impairment. Monitor liver, visual function in long-term use. Pregnancy (Cat.C); use adequate contraception. Nursing mothers: not recommended.

Interactions:

Do not use during or within 12 hours of quinine, quinidine, chloroquine (may cause seizures or ECG changes); caution with drugs that cause QTc prolongation (eg, β-blockers). Do not use halofantrine or ketoconazole during or within 15 weeks of last mefloquine dose. Caution with rifampin. May affect or be affected by CYP3A4 inhibitors or inducers, p-glycoprotein substrates. May antagonize antiepileptics. Complete live oral bacterial vaccinations (eg, typhoid) at least 3 days before 1st mefloquine dose. Monitor anticoagulants, antidiabetics, antiepileptics 2–3 weeks before departure.

Pharmacological Class:

Aminoquinoline.

Adverse Reactions:

Vomiting, dizziness, vertigo, syncope, extrasystoles, myalgias, fever, headache, chills, diarrhea, rash, abdominal pain, fatigue, anorexia, tinnitus; rare: seizures, cardiac arrest, encephalopathy, CNS/emotional disturbances.

How Supplied:

Contact supplier.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs